A detailed history of Advisor Group Holdings, Inc. transactions in Cryo Cell International Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,000 shares of CCEL stock, worth $15,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,000
Previous 2,500 20.0%
Holding current value
$15,000
Previous $18,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$6.7 - $9.38 $3,350 - $4,690
-500 Reduced 20.0%
2,000 $15,000
Q4 2023

Feb 12, 2024

SELL
$4.19 - $6.6 $8,380 - $13,200
-2,000 Reduced 44.44%
2,500 $14,000
Q3 2023

Nov 13, 2023

BUY
$5.03 - $7.04 $10,060 - $14,080
2,000 Added 80.0%
4,500 $23,000
Q1 2023

May 12, 2023

BUY
$2.97 - $4.66 $1,485 - $2,330
500 Added 25.0%
2,500 $7,000
Q1 2022

May 04, 2022

BUY
$7.28 - $11.84 $14,560 - $23,680
2,000 New
2,000 $15,000

Others Institutions Holding CCEL

About CRYO CELL INTERNATIONAL INC


  • Ticker CCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 8,519,250
  • Market Cap $63.9M
  • Description
  • Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...
More about CCEL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.